BRASKEM SA
BAK · XNYSCIK 1071438fmd_06BKZV7JEZW6ZMJZQ21Y8TA44XManufacturing · Industrial Organic ChemicalsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 13 periods
Latest annual · FY2024
Millions- Total revenues
- 77,411
- Gross profit
- 5,997
- Operating income
- (1,079)
- Net income
- (11,320)
- Free cash flow
- (1,326)
Latest quarter · Q4 FY2021
Millions- Total revenues
- 28,212
- Gross profit
- 6,702
- Operating income
- 4,626
- Net income
- 1,127
- Free cash flow
- 2,855
Daily close · BAKIEX trades only
Nov 13, 2025 to Nov 11, 2026 · 250 sessions1.08 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- -9.8%
- Revenue, 5 yearsFY2019 to FY2024
- +8.1%
- Net income, 5 yearsFY2019 to FY2024
- n/m
BRASKEM SA (BAK) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | R$77.4 billion | R$70.6 billion | +9.7% | 20-F 2025-03-31 · proof |
| Gross profit | R$6 billion | R$3 billion | +98.5% | 20-F 2025-03-31 · proof |
| Operating income | -R$1.1 billion | -R$2.8 billion | 20-F 2025-03-31 · proof | |
| Net income | -R$11.3 billion | -R$4.6 billion | 20-F 2025-03-31 · proof | |
| Cash from operating activities | R$2.4 billion | -R$2.3 billion | 20-F 2025-03-31 · proof | |
| Free cash flow | -R$1.3 billion | -R$6.8 billion | 20-F 2025-03-31 · proof | |
| Total assets | R$101.6 billion | R$91.7 billion | +10.7% | 20-F 2025-03-31 · proof |
| Total liabilities | R$105.9 billion | R$88.5 billion | +19.7% | 20-F 2025-03-31 · proof |
| Cash and cash equivalents | R$15 billion | R$14.2 billion | +5.6% | 20-F 2025-03-31 · proof |
| Total debt | R$65.2 billion | R$50.7 billion | +28.6% | 20-F 2025-03-31 · proof |
- What was BRASKEM SA (BAK)'s revenue in fiscal 2024?
- BRASKEM SA (BAK) reported revenue of R$77.4 billion for fiscal 2024 (the year ended Dec 31, 2024), against R$70.6 billion the year before (+9.7%). Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What was BRASKEM SA (BAK)'s gross profit in fiscal 2024?
- BRASKEM SA (BAK) reported gross profit of R$6 billion for fiscal 2024 (the year ended Dec 31, 2024), against R$3 billion the year before (+98.5%). Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What was BRASKEM SA (BAK)'s operating income in fiscal 2024?
- BRASKEM SA (BAK) reported operating income of -R$1.1 billion for fiscal 2024 (the year ended Dec 31, 2024), against -R$2.8 billion the year before. Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What was BRASKEM SA (BAK)'s net income in fiscal 2024?
- BRASKEM SA (BAK) reported net income of -R$11.3 billion for fiscal 2024 (the year ended Dec 31, 2024), against -R$4.6 billion the year before. Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What was BRASKEM SA (BAK)'s cash from operating activities in fiscal 2024?
- BRASKEM SA (BAK) reported cash from operating activities of R$2.4 billion for fiscal 2024 (the year ended Dec 31, 2024), against -R$2.3 billion the year before. Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What was BRASKEM SA (BAK)'s free cash flow in fiscal 2024?
- BRASKEM SA (BAK) reported free cash flow of -R$1.3 billion for fiscal 2024 (the year ended Dec 31, 2024), against -R$6.8 billion the year before. Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What are BRASKEM SA (BAK)'s total assets?
- As of Dec 31, 2024, BRASKEM SA (BAK) reported total assets of R$101.6 billion, against R$91.7 billion a year earlier (+10.7%). Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What are BRASKEM SA (BAK)'s total liabilities?
- As of Dec 31, 2024, BRASKEM SA (BAK) reported total liabilities of R$105.9 billion, against R$88.5 billion a year earlier (+19.7%). Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What are BRASKEM SA (BAK)'s cash and cash equivalents?
- As of Dec 31, 2024, BRASKEM SA (BAK) reported cash and cash equivalents of R$15 billion, against R$14.2 billion a year earlier (+5.6%). Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
- What is BRASKEM SA (BAK)'s total debt?
- As of Dec 31, 2024, BRASKEM SA (BAK) reported total debt of R$65.2 billion, against R$50.7 billion a year earlier (+28.6%). Source: the 20-F filed with the SEC on Mar 31, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BAK&period_type=annual&limit=5"Information only, not investment advice.